Monocytes of Different Subsets in Complexes with Platelets in Patients with Myocardial Infarction

Marina Loguinova; Natalia Pinegina; Valeria Kogan; Murad Vagida; Anush Arakelyan; Alexander Shpektor; Leonid Margolis; Elena Vasilieva

doi:10.1055/s-0038-1673342

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2018; 118(11): 1969-1981
DOI: 10.1055/s-0038-1673342

Atherosclerosis and Ischaemic Disease

Georg Thieme Verlag KG Stuttgart · New York

Monocytes of Different Subsets in Complexes with Platelets in Patients with Myocardial Infarction

Authors

Marina Loguinova^*

¹Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia
Natalia Pinegina^*

¹Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia
Valeria Kogan

²Ariel University, Institute for Translational Research, Ariel, Israel
Murad Vagida

¹Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia
Anush Arakelyan

³Section on Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States
Alexander Shpektor

¹Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia
Leonid Margolis

³Section on Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States
Elena Vasilieva

¹Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia

Abstract

Acute myocardial infarction (AMI) is associated with activation of various cells, including platelets that form monocyte–platelet complexes (MPCs). Here, we analysed MPC in vivo and in vitro and investigated the abilities of different monocyte subclasses to form MPC, the characteristics of the cells involved in MPC formation and MPC changes in AMI. We identified MPC by co-staining for platelet antigen CD41a and monocyte antigens CD14 and CD16. Platelet activation was evaluated from expression of phosphatidylserine as revealed by annexin V. Our results confirm published data and provide new information regarding the patterns of MPC in AMI patients. We found that the patterns of platelet aggregation with monocytes were different in AMI patients and controls: (1) in AMI patients, MPC formed by intermediate monocytes carry more platelets whereas in healthy controls more platelets aggregated with classical monocytes; (2) the numbers of MPC in AMI patients, being already higher than in controls, were further increased if these patients suffered various in-hospital complications; (3) on the basis of the CD41a fluorescence of the antibody-stained MPC, some of the aggregates seem to consist of monocytes and platelet-derived extracellular vesicles (EVs); (4) aggregation of monocytes with platelet EV occurred in in vitro experiments; and (5) these experiments demonstrated that monocytes from AMI patients aggregate with both platelets and platelet EVs more efficiently than do monocytes from controls. MPC in AMI patients may play an important role in this pathology.

Keywords

monocyte subsets - monocyte–platelet complexes - extracellular vesicles - acute myocardial infarction - flow cytometry

Full Text

References

References
1 Shantsila E, Lip GYH. Monocytes in acute coronary syndromes. Arterioscler Thromb Vasc Biol 2009; 29 (10) 1433-1438
2 Fang L, Moore X-L, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol 2015; 12 (03) 305-312
3 Cerletti C, de Gaetano G, Lorenzet R. Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. Mediterr J Hematol Infect Dis 2010; 2 (03) e2010023
4 Furman MI, Benoit SE, Barnard MR. , et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31 (02) 352-358
5 Irving PM, Macey MG, Shah U, Webb L, Langmead L, Rampton DS. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis 2004; 10 (04) 361-372
6 Ferroni P, Basili S, Falco A, Davì G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2004; 2 (08) 1282-1291
7 Johansson MW, Han ST, Gunderson KA, Busse WW, Jarjour NN, Mosher DF. Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma. Am J Respir Crit Care Med 2012; 185 (05) 498-507
8 Singh MV, Davidson DC, Jackson JW. , et al. Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation. J Immunol 2014; 192 (10) 4674-4684
9 Mayne E, Funderburg NT, Sieg SF. , et al. Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr 2012; 59 (04) 340-346
10 Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104 (13) 1533-1537
11 da Costa Martins PA, van Gils JM, Mol A, Hordijk PL, Zwaginga JJ. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 2006; 79 (03) 499-507
12 Li N, Hu H, Lindqvist M, Wikström-Jonsson E, Goodall AH, Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000; 20 (12) 2702-2708
13 Furman MI, Barnard MR, Krueger LA. , et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38 (04) 1002-1006
14 Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost 2012; 10 (07) 1231-1241
15 Zhou X, Liu XL, Ji WJ. , et al. The kinetics of circulating monocyte subsets and monocyte-platelet aggregates in the acute phase of ST-elevation myocardial infarction associations with 2-year cardiovascular events. Medicine (Baltimore) 2016; 95 (18) e3466
16 Weiss R, Gröger M, Rauscher S. , et al. Differential interaction of platelet-derived extracellular vesicles with leukocyte subsets in human whole blood. Sci Rep 2018; 8 (01) 6598
17 Thygesen K, Alpert JS, Jaffe AS. , et al; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J 2012; 33 (20) 2551-2567
18 Ibanez B, James S, Agewall S. , et al; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39 (02) 119-177
19 Harding SA, Din JN, Sarma J. , et al. Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost 2007; 98 (02) 451-456
20 Weber C, Shantsila E, Hristov M. , et al. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups “Atherosclerosis & Vascular Biology” and “Thrombosis”. Thromb Haemost 2016; 116 (04) 626-637
21 Cazenave JP, Ohlmann P, Cassel D, Eckly A, Hechler B, Gachet C. Preparation of washed platelet suspensions from human and rodent blood. Methods Mol Biol 2004; 272: 13-28
22 Dinkla S, Brock R, Joosten I, Bosman GJ. Gateway to understanding microparticles: standardized isolation and identification of plasma membrane-derived vesicles. Nanomedicine (Lond) 2013; 8 (10) 1657-1668
23 Murphy AJ, Tall AR. Disordered haematopoiesis and athero-thrombosis. Eur Heart J 2016; 37 (14) 1113-1121
24 Poncelet P, Robert S, Bouriche T, Bez J, Lacroix R, Dignat-George F. Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: forward or side scatter?. Cytometry A 2016; 89 (02) 148-158
25 Ayers L, Kohler M, Harrison P. , et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011; 127 (04) 370-377
26 Panteleev MA, Ananyeva NM, Greco NJ, Ataullakhanov FI, Saenko EL. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex. J Thromb Haemost 2005; 3 (11) 2545-2553
27 Margolis L. Immunoactivation at the crossroads of human disease. Am J Med 2015; 128 (06) 562-566
28 Funderburg NT, Mayne E, Sieg SF. , et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 2010; 115 (02) 161-167
29 Grivel J-C, Ivanova O, Pinegina N. , et al. Activation of T lymphocytes in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2011; 31 (12) 2929-2937
30 Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 2014; 14 (03) 195-208
31 Gutiérrez-Vázquez C, Villarroya-Beltri C, Mittelbrunn M, Sánchez-Madrid F. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev 2013; 251 (01) 125-142
32 Badimon L, Suades R, Fuentes E, Palomo I, Padró T. Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis. Front Pharmacol 2016; 7: 293
33 Vagida M, Arakelyan A, Lebedeva A. , et al. Flow analysis of individual blood extracellular vesicles in acute coronary syndrome. Platelets 2017; 28 (02) 165-173
34 Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol 2010; 30 (12) 2357-2361
35 Sarma J, Laan CA, Alam S, Jha A, Fox KA, Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002; 105 (18) 2166-2171
36 Wrigley BJ, Shantsila E, Tapp LD, Lip GY. Increased formation of monocyte-platelet aggregates in ischemic heart failure. Circ Heart Fail 2013; 6 (01) 127-135
37 Lindemann S, Krämer B, Daub K, Stellos K, Gawaz M. Molecular pathways used by platelets to initiate and accelerate atherogenesis. Curr Opin Lipidol 2007; 18 (05) 566-573
38 Shantsila E, Lip GYH. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost 2009; 102 (05) 916-924
39 Ed Rainger G, Chimen M, Harrison MJ. , et al. The role of platelets in the recruitment of leukocytes during vascular disease. Platelets 2015; 26 (06) 507-520
40 Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010; 121 (22) 2437-2445
41 Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now?. J Am Coll Cardiol 2013; 62 (17) 1541-1551
42 Rogacev KS, Cremers B, Zawada AM. , et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 2012; 60 (16) 1512-1520
43 Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol 1996; 16 (01) 51-55
44 Michelson AD. Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 2006; 35 (1-2): 67-82
45 Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 2005; 3 (10) 2185-2192
46 Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991; 78 (07) 1760-1769
47 Żmigrodzka M, Guzera M, Miśkiewicz A, Jagielski D, Winnicka A. The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression. Tumour Biol 2016; 37 (11) 14391-14401
48 Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010; 123 (Pt 10): 1603-1611
49 Chiva-Blanch G, Laake K, Myhre P. , et al. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity. PLoS One 2017; 12 (02) e0172558

Supplementary Material

Supplementary Material (PDF) (opens in new window)